Prestige Consumer Healthcare (NYSE:PBH) Reaches New 52-Week Low Following Weak Earnings

Key Points

• Prestige Consumer Healthcare shares hit a new 52-week low of $64.41 following a disappointing earnings report, with a miss in EPS at $0.95 compared to the expected $1.01.
• The company's revenue for the quarter was reported at $249.53 million, falling short of the $260.71 million consensus estimate and representing a year-over-year decrease of 6.6%.
• Despite the recent challenges, several analysts have maintained a Moderate Buy consensus rating for Prestige, with a target price set at $93.33.

Prestige Consumer Healthcare Inc. (NYSE:PBH - Get Free Report)'s stock price hit a new 52-week low on Friday following a dissappointing earnings announcement. The stock traded as low as $64.41 and last traded at $64.83, with a volume of 82031 shares changing hands. The stock had previously closed at $67.61.

The company reported $0.95 earnings per share for the quarter, missing analysts' consensus estimates of $1.01 by ($0.06). The company had revenue of $249.53 million for the quarter, compared to analyst estimates of $260.71 million. Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%. The business's revenue was down 6.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.90 earnings per share.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the stock. Wall Street Zen cut shares of Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research report on Saturday. Royal Bank Of Canada raised shares of Prestige Consumer Healthcare to a "hold" rating in a research note on Thursday, May 8th. Finally, Canaccord Genuity Group cut their price objective on shares of Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating on the stock in a report on Friday. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $93.33.

Institutional Trading of Prestige Consumer Healthcare

A number of institutional investors and hedge funds have recently modified their holdings of the company. Franklin Resources Inc. lifted its stake in shares of Prestige Consumer Healthcare by 0.7% during the fourth quarter. Franklin Resources Inc. now owns 21,735 shares of the company's stock valued at $1,697,000 after acquiring an additional 150 shares during the period. Wells Fargo & Company MN increased its holdings in shares of Prestige Consumer Healthcare by 103.0% in the fourth quarter. Wells Fargo & Company MN now owns 199,449 shares of the company's stock worth $15,575,000 after acquiring an additional 101,179 shares in the last quarter. Envestnet Asset Management Inc. grew its holdings in shares of Prestige Consumer Healthcare by 124.4% during the fourth quarter. Envestnet Asset Management Inc. now owns 169,926 shares of the company's stock worth $13,270,000 after buying an additional 94,192 shares in the last quarter. Bank of Montreal Can grew its holdings in shares of Prestige Consumer Healthcare by 15.1% during the fourth quarter. Bank of Montreal Can now owns 7,127 shares of the company's stock worth $557,000 after buying an additional 937 shares in the last quarter. Finally, Invesco Ltd. boosted its position in Prestige Consumer Healthcare by 2.4% during the fourth quarter. Invesco Ltd. now owns 1,060,263 shares of the company's stock valued at $82,796,000 after purchasing an additional 24,392 shares during the last quarter. 99.95% of the stock is currently owned by institutional investors.

Prestige Consumer Healthcare Stock Up 1.6%

The stock has a market capitalization of $3.19 billion, a price-to-earnings ratio of 15.30, a PEG ratio of 1.98 and a beta of 0.43. The firm has a 50-day moving average of $78.83 and a 200 day moving average of $82.00. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.38 and a quick ratio of 2.99.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.